Literature DB >> 31676908

DNA damage and repair in neuropsychiatric disorders. What do we know and what are the future perspectives?

Piotr Czarny1, Katarzyna Bialek2, Sylwia Ziolkowska1, Justyna Strycharz1, Tomasz Sliwinski2.   

Abstract

Over the past two decades, extensive research has been done to elucidate the molecular etiology and pathophysiology of neuropsychiatric disorders. In majority of them, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), bipolar disorder (BD), schizophrenia and major depressive disorder, increased oxidative and nitrosative stress was found. This stress is known to induce oxidative damage to biomolecules, including DNA. Accordingly, increased mitochondrial and nuclear DNA, as well as RNA damage, were observed in patients suffering from these diseases. However, recent findings indicate that the patients are characterised by impaired DNA repair pathways, which may suggest that these DNA lesions could be also a result of their insufficient repair. In the current systematic, critical review, we aim to sum up, using available literature, the knowledge about the involvement of nuclear and mitochondrial DNA damage and repair, as well as about damage to RNA in pathoetiology of neuropsychiatric disorders, i.e., AD, PD, ALS, BD, schizophrenia and major depressive disorder, as well as the usefulness of the discussed factors as being diagnostic markers and targets for new therapies. Moreover, we also underline the new directions to which future studies should head to elucidate these phenomena.
© The Author(s) 2019. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 31676908     DOI: 10.1093/mutage/gez035

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  6 in total

1.  Implications of DNA damage and DNA repair on human diseases.

Authors:  Bryant C Nelson; Miral Dizdaroglu
Journal:  Mutagenesis       Date:  2020-02-13       Impact factor: 3.000

2.  NADPH-oxidase 4 gene over-expression in peripheral blood lymphocytes of the schizophrenia patients.

Authors:  Elizaveta S Ershova; Galina V Shmarina; Andrey V Martynov; Natalia V Zakharova; Roman V Veiko; Pavel E Umriukhin; George P Kostyuk; Sergey I Kutsev; Natalia N Veiko; Svetlana V Kostyuk
Journal:  PLoS One       Date:  2022-06-13       Impact factor: 3.752

Review 3.  Genome Integrity and Neurological Disease.

Authors:  Elle E M Scheijen; David M Wilson
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

4.  An Association Study of DNA Methylation and Gene Expression in Angelman Syndrome: A Bioinformatics Approach.

Authors:  Julia Panov; Hanoch Kaphzan
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

5.  CometChip analysis of human primary lymphocytes enables quantification of inter-individual differences in the kinetics of repair of oxidative DNA damage.

Authors:  Le P Ngo; Simran Kaushal; Isaac A Chaim; Patrizia Mazzucato; Catherine Ricciardi; Leona D Samson; Zachary D Nagel; Bevin P Engelward
Journal:  Free Radic Biol Med       Date:  2021-07-26       Impact factor: 8.101

6.  KEOPS complex expression in the frontal cortex in major depression and schizophrenia.

Authors:  Mackenzie E Abel; Xiaolu Zhang; Sophie M Asah; Alyssa Wolfinger; Robert E McCullumsmith; Sinead M O'Donovan
Journal:  World J Biol Psychiatry       Date:  2020-09-29       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.